Yesterday, the FDA approved a drug called Provenge. It trains the body’s immune system to fight off advanced prostate cancer. It’s also the first proof we have that immunotherapy works in the fight against the disease.
Researchers have discovered an antibody which, when injected into mice, will bond with prostate cancer tissue and “initiate direct cell death” in it. If results carry over to humans, this discovery would almost be a cure to prostate cancer.
